TCI Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

TCI Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-180	Closed	–	–	1753
2018 Q3	$0	Buy	+180	New	+$385	﹤0.01%	1645

Other funds holding ZOM

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCI Wealth Advisors's ZOM Position: Q4 2018 in Review

TCI Wealth Advisors sold out of Zomedica Corp. (ZOM) in Q4 2018, closing a stake of 180 shares.

TCI Wealth Advisors first reported a position in ZOM in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 35 funds tracked by Wall St. Rank hold ZOM as of Q4 2018.

TCI Wealth Advisors reported no remaining Zomedica Corp. position as of Q4 2018 after selling out during the quarter.
TCI Wealth Advisors sold 180 Zomedica Corp. shares in Q4 2018.
TCI Wealth Advisors first reported a position in Zomedica Corp. in Q3 2018 and held it in 1 quarter.
TCI Wealth Advisors's Zomedica Corp. position peaked at $0 in Q3 2018.
35 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2018.

Based on TCI Wealth Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.